Poster Abstracts - C717



Articles

Dendritic Cell-based Vaccine for Complementary Therapy of High Grade Glioma Patients using the CliniMACS Platform for Large-scale Clinical Production


Identification: 1001


Modeling Tumor Immuno-Dynamics to Predict Patient Survival & Immunotherapy Efficacy


Identification: 1002


Targeting myeloid derived suppressor cells to attenuate glioblastoma growth


Identification: 1003


An analysis of expression of Immune checkpoint biomarkers in 15,454 patients with adverse pathology after radical prostatectomy: initial results from the Decipher GRID


Identification: 1004


Class II-restricted tumor antigens can function to either promote or inhibit vaccine induced protective anti-tumor responses


Identification: 1005


Engineering adoptive T cell therapy for efficacy in ovarian cancer


Identification: 1007


Myeloid Derived Suppressor Cells Arising from Tumor Resections Severely Suppresses Natural Killer Cells ex vivo


Identification: 1008


Depletion of tumor-infiltrating regulatory T cells with anti-CD25 requires Fc-optimization and synergizes with PD-1 blockade to eradicate established tumors


Identification: 1010


Humanized mouse; A model for understanding tumor-immune system interactions


Identification: 1012


HIFU improves the therapeutic efficacy of dendritic cell vaccine in mouse melanoma model


Identification: 1014

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content